All Articles

reAlpha Mortgage is ditching traditional commissions for a flat-fee model with stock options and AI. A bold commercialization play in the war for loan officers.

A small biotech's dual-front war on cancer reveals a powerful new playbook: leveraging elite partnerships to pioneer a preventative vaccine and a novel CAR-T.

A new customs deal with Uruguay isn't just stopping smugglers. It's a key move to secure supply chains, de-risk a $317M trade route, and pave the way for a larger FTA with South America's MERCOSUR bloc.

How did a single Korean serum dethrone skincare giants on Amazon? Meditherapy's rise reveals a new blueprint for brand building in the digital age.

Nasdaq-listed Jinxin Technology is betting its future on AI companions, moving from content to hardware to capture a slice of China's booming children's AI market.

First Responders Children's Foundation and T-Mobile are disrupting recognition by letting the public nominate heroes, a strategic shift in community engagement.

As clients demand simplicity, Clever, GLGR, and The Right Now merge to form Punch Group, betting that an integrated model is the future of marketing.

A proxy fight pits Vaxart's experienced board against dissident shareholders demanding accountability, with the future of its innovative pill vaccines at stake.

By investing in startups like Magdent and Oral Genome, Dentalcorp is signaling a strategic shift, redefining the role of DSOs from managers to innovation engines.

As Ontario's lowest-paid nurses demand fair wages from the Victorian Order of Nurses, their fight exposes a deep crisis threatening the province's home-care strategy.

A new Redfin survey reveals overwhelming bipartisan support for housing affordability policies, creating a powerful public mandate for a landmark bill now stalled.

In a first for muscular dystrophy, Epicrispr's EPI-321 didn't just slow the disease—it increased lean muscle volume, signaling a new era for gene therapy.

Upexi joins the Russell Microcap Index, a milestone for any firm. But with a treasury heavy on volatile Solana, is this a new model for investors or a cautionary tale?

The Subaru Ascent's top quality award is more than a trophy. It's a look into how corporate values, from the factory floor to the family car, build trust.

A new partnership between Remote and isolved embeds global hiring into a major US HR platform, turning international expansion from a legal maze into a simple click.

Fresh off a reverse merger, American Gold & Copper Inc. pivots to US soil, signing a deal for a promising copper-gold project in Nevada's famed Battle Mountain.

With its new Museum of Exploration, National Geographic is gambling that high-tech immersion and a premium price tag can capture a new generation of explorers.

A landmark trial in Hawaiʻi brings together a tech innovator, a regional airline, and a legacy carrier to test the future of electric island hopping.

After a tumultuous delisting from Nasdaq, Luna Innovations finds a new home with TJC, trading public market woes for private equity's deep pockets.

A rare disease drug's EU approval is revoked over 'misleading' data, impacting patients and signaling a new era of strict regulatory scrutiny for pharma giants.